Que Sera Sera
whatever will be, will be...so I hope I'm prepared
Sharing a great post: Celgene Reports More Good Crohn's Disease Data CELG
Celgene rolled out more upbeat data on its new Crohn's disease drug, sending the biotech giant's shares 3% higher on Tuesday.
10/23/2014 07:11:00 PM
Post a Comment
Post Comments (Atom)